A comparative analysis of histone deacetylase inhibitors for the treatment of mycosis fungoides and Sézary syndrome
British Journal of Dermatology2019Vol. 182(2), pp. 497–498
Citations Over Time
Theone Papps, Christopher McCormack, Odette Buelens, Carrie van der Weyden, Robert Twigger, Belinda A. Campbell, Michael Dickinson, H. Miles Prince
Related Papers
- → A Structural Insight into Hydroxamic Acid Based Histone Deacetylase Inhibitors for the Presence of Anticancer Activity(2013)65 cited
- Design, synthesis, and biological evaluation of N-hydroxycinnamamide/salicylic acid hybrids as histone deacetylase inhibitors(2014)
- → Synthesis, characterization, and vitro evaluation of new materials in vorinostat analogs containing biomolecules(2021)2 cited
- Progress in clinical trial of histone deacetylase (HDAC) inhibitors for non-small cell lung cancers*(2014)
- Mycosis fungoides treated with Puva and Topical Corticosteroids.(2012)